Company Filing History:
Years Active: 1997
Title: Inventor Spotlight: Steven I Dworetzky
Introduction
Steven I Dworetzky, located in Middletown, CT, is a distinguished inventor who has made significant contributions to the field of medical therapies. With his extensive knowledge and innovative thinking, he has been granted a patent that addresses crucial health challenges.
Latest Patents
Dworetzky's notable patent is titled "Method for regulation of transmembrane chloride conductance." This invention focuses on therapeutic methods for cystic fibrosis and multi-drug resistance in cancer chemotherapy. The patent specifically details the administration of 5-trifluoroethyl-1-(5-chloro-2-hydroxyphenyl)-1,3-dehydro-2H-benzimidazol-2-one (NSOO4) or a pharmaceutically acceptable salt thereof to patients in need.
Career Highlights
Dworetzky is employed at Bristol-Myers Squibb Company, a renowned pharmaceutical company known for its commitment to discovering and developing innovative medicines. His work at this esteemed organization has enabled him to play a pivotal role in advancing medical science and improving patient outcomes.
Collaborations
Throughout his career, Steven I Dworetzky has worked alongside remarkable professionals, including Valentin K Gribkoff and Davis L Temple. Collaborating with such talented individuals has likely enhanced his research efforts and broadened the impact of his inventions.
Conclusion
Steven I Dworetzky is a prominent figure in the world of innovation and medical advancements. Through his patent and collaborative efforts at Bristol-Myers Squibb Company, he continues to contribute to vital therapeutic methods that can improve the lives of many patients suffering from challenging health conditions. His dedication to innovation sets a notable example in the field of medical invention.